<DOC>
	<DOCNO>NCT02136784</DOCNO>
	<brief_summary>The aim study examine effect opioid analgesic acute pain participant maintain buprenorphine+naloxone ( Suboxone ) opioid use disorder . Seven medication condition test cold pressor test ( CPT ) paradigm .</brief_summary>
	<brief_title>Analgesic Response Opioid Analgesics Buprenorphine-Maintained Individuals</brief_title>
	<detailed_description>Study design single-blind examination analgesic effect single dose seven test medication provide experimental pain paradigm use cold pressor test ( CPT ) . Test medication condition include buprenorphine , morphine , hydromorphone , hydrocodone , oxycodone , two placebo condition match test medication formulation ( oral tablet , sublingual tablet ) . Each medication condition test separate day ( seven total day , complete within 12 week ) , random assignment order study medication . After screen , eligible participant schedule 7 day test test day least 3 day apart provide sufficient medication wash-out period . Pain test utilize cold pressor test ( CPT ) , participant submerges arm hand bath ice cold water determine pain threshold tolerance . Participants give practice trial provide familiarity test reduce test anxiety . Two CPTs occur test day , pre- post-CPT assessment administer . Blood sample take test day measure blood level buprenorphine . Daily procedure include : ( 1 ) A baseline CPT ( BL-CPT ) , ( 2 ) Administration test medication ( active drug placebo ) , ( 3 ) CPT administer time maximum drug effect ( Tmax-CPT ) specific medication ( range 30-120 minute ) , ( 4 ) Pupillometry conduct baseline ( BL-CPT ) , time maximum drug effect ( Tmax-CPT ) . Each participant discharge clinical determination participant 's safety well-being . Testing continue twelve trial medication condition complete .</detailed_description>
	<mesh_term>Morphine</mesh_term>
	<mesh_term>Analgesics , Opioid</mesh_term>
	<mesh_term>Hydromorphone</mesh_term>
	<mesh_term>Hydrocodone</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<mesh_term>Oxycodone</mesh_term>
	<mesh_term>Analgesics</mesh_term>
	<criteria>1 . Male , good general health 2 . 2050 year old 3 . Fluent English 4 . Maintained buprenorphine least 3 month 5 . Able complete testing/assessments 7 test day within 12 week 6 . Approved participation buprenorphineprescribing physician 1 . Known hypersensitivity test opioids 2 . Urine test positive opioids ( buprenorphine ) illicit substances 3 . Current use additional opioid analgesic medication ( buprenorphine ) , medical marijuana , MAOI , tricyclic antidepressant , duloxetine , gabapentin , pregabalin , medication consider unsafe potential influence pain perception determine study physician . 4 . Presence acute pain condition plan surgery study period 5 . Unstable vital sign determine study physician . 6 . Current pattern alcohol , benzodiazepine , sedative hypnotic use , determine study medical clinician , would preclude safe participation study ; 7 . Pending legal action situation might prevent remain area duration study 8 . Current medical psychiatric condition could detract study objective , place participant risk , interfere treatment goal</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>pain</keyword>
	<keyword>cold presser test</keyword>
	<keyword>buprenorphine</keyword>
	<keyword>opioids</keyword>
</DOC>